Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Ovarian Cancer Clinical Trials
Ovarian Cancer clinical trials are recruiting across 178 cities. Here are the cities with the most active studies:
Ovarian Cancer Trial Phases
67 research organizations are sponsoring ovarian cancer trials.
About Ovarian Cancer
Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.
Clinical trials are advancing new treatments for ovarian cancer. Currently, 100 studies are recruiting a combined 141,730 participants across the United States. Research is being conducted by 67 organizations including John R van Nagell, OHSU Knight Cancer Institute, M.D. Anderson Cancer Center and 64 others.
2026 Ovarian Cancer Research Landscape
As of July 2026, the ovarian cancer clinical trial landscape includes 100 actively recruiting studies across 178 cities in the United States. These studies are collectively seeking 141,730 participants, with an average enrollment target of 1,417 per study.
The research spans multiple phases of development: 32 studies are in PHASE2, 31 studies are in PHASE1, 17 studies are in NA, 17 studies are in PHASE3, 2 studies are in EARLY_PHASE1, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some ovarian cancer treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 67 different organizations, including John R van Nagell, OHSU Knight Cancer Institute, M.D. Anderson Cancer Center, Northwestern University, Mayo Clinic, and 62 others. The large number of sponsors reflects significant research interest and investment in ovarian cancer treatment advancement.
Geographically, ovarian cancer trials are most concentrated in Boston, Massachusetts (23 trials); Houston, Texas (22 trials); New York, New York (20 trials); Los Angeles, California (14 trials); Miami, Florida (12 trials) and 7 other cities.
Featured Ovarian Cancer Studies
Highlighted recruiting studies for ovarian cancer, selected by enrollment size and research scope.
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
This is a large, prospective, single-arm cohort study of transvaginal ultrasonographic screening for ovarian cancer in intermediate to high-risk women from Kentucky. Detection of ovarian malignancy often occurs subsequent to the initial transvaginal sonography (TVS) screen; therefore, it is important to offer continued screening to study participants based on our published algorithm. Screening wil...
Identifying and Caring for Individuals With Inherited Cancer Syndrome
This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general public. Researchers hope to learn the value of providing broad, public-wide testing for high risk cancer types (like hereditary breast and ovarian cancer or Lynch syndromes) instead of only testing people whose families are...
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
The goal of this clinical research study is to find out if combining a standard blood test (CA-125) that checks for ovarian cancer with other blood tests that check for related tumor markers may be helpful in the early detection of ovarian cancer in women who are at low risk. Tumor markers are substances in the blood that may be related to ovarian cancer.
Frequently Asked Questions About Ovarian Cancer Clinical Trials
Are there ovarian cancer clinical trials near me?
Yes, there are 100 ovarian cancer clinical trials currently recruiting across 178+ cities in the United States, including Boston, Massachusetts; Houston, Texas; New York, New York. Browse the studies above to find one at a location convenient for you.
How do I join a ovarian cancer clinical trial?
To join a ovarian cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are ovarian cancer clinical trials free?
Yes, participation in ovarian cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of ovarian cancer treatments are being studied?
Current ovarian cancer clinical trials are testing a range of approaches across PHASE2 (32 studies), PHASE1 (31 studies), NA (17 studies), PHASE3 (17 studies), EARLY_PHASE1 (2 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 67 research organizations.
Is it safe to participate in ovarian cancer clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 18, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 18, 2026 · Data from ClinicalTrials.gov